Skin Cancer | Tumor

Friday Frontline: Beirut Explosion Costs Children’s Access to Cancer Treatment, Researchers Find Intestinal Bacteria ‘Supercharges’ Immunotherapy and More

August 14th 2020

From the recent Beirut explosion compromising pediatric oncology hospitals, to researchers looking at how intestinal bacteria can supercharge targeted immunotherapies, here’s what’s happening in the cancer landscape this week.

FDA Approves Tecentriq in Combination with Cotellic and Zelboraf for Patients with Advanced Skin Cancer

July 31st 2020

The Food and Drug Administration has approved Tecentriq in combination with Cotellic and Zelboraf for the treatment of patients with BRAF V600 mutation-positive advanced melanoma.

The Future of Melanoma Treatment May Be Complex, But 'Where There's a Will, There's a Way'

July 28th 2020

Research in the melanoma space is finding itself facing complex challenges in implementing CAR-T cell therapy, but according to one expert these challenges are not insurmountable.

Investigating a Health Gap in Skin Cancer

July 23rd 2020

CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma

July 11th 2020

“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”

Speaking Out: Taking Action Against Skin Cancer

July 4th 2020

Patients can pick from a growing array of treatments, from same-day- results surgery to game-changing immunotherapy, to fight the most common type of cancer.

FDA Approves Keytruda for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma

June 24th 2020

The Food and Drug Administration approved Keytruda to treat patients with recurrent or metastatic cutaneous squamous cell carcinoma that cannot be treated with surgery or radiation.

Tafinlar and Mekinist Improve Long-Term Survival in Patients with BRAF Positive Melanoma

June 19th 2020

“The relapse-free survival curves for both treatment arms appear to be reaching a plateau, which is a good sign if we are talking about cure,” said lead study author Dr. Axel Hauschild.

Friday Frontline: Cancer Updates, Research and Education on May 29, 2020

May 29th 2020

From a five-year-old patient with liver cancer receiving a birthday surprise to a mother-daughter duo releasing a children’s book to help families going through breast cancer treatment, here’s what is making headlines in the cancer space this week.

A Melanoma Survivor During Skin Cancer Awareness Month

May 23rd 2020

During Skin Cancer Awareness Month, one melanoma survivor reflects on her treatment and the preventive measures everyone should take to avoid skin cancer.

Friday Frontline: Cancer Updates, Research and Education on May 15, 2020

May 15th 2020

From influential musician Little Richard passing away due to bone cancer to a dramatic drop in new cancer diagnoses as screenings have been postponed as a result of COVID-19, here are all the major updates happening in the cancer space this week.

Raising Awareness Around Skin Cancer

May 1st 2020

What's on the Horizon in Skin Cancer Treatment

May 1st 2020

New, Unusual or Changing: How to Detect Skin Cancer

May 1st 2020

Learning Types of Skin Cancer and Who Is At Risk

May 1st 2020

Combining Novel Drugs and Using Surgery at Key Moments Defines Modern Melanoma Treatment

April 27th 2020

Dr. Omid Hamid discusses combining targeted drugs and immunotherapy, the role of surgery and ongoing research efforts in melanoma.

T-Cell Therapies Show Promise in Metastatic Melanoma, But Challenges Remain

April 24th 2020

With the growing and evolving field of T-cell therapies, patients with metastatic melanoma have new hopes for effective treatment, but the treatment faces future clinical challenges.

How Can Cancer Survivors Survive COVID-19?

March 28th 2020

What can cancer survivors do to cope and process the scale of the COVID-19 pandemic?

A Multi-Pronged Approach to Fighting Cancer Fatigue

March 21st 2020

Breast cancer and melanoma cancer survivor learned that a combination of changes helped her beat fatigue after cancer treatments.

CURE's Top Stories: February 2020

March 2nd 2020

Here are the top five CURE® stories for February 2020.

Skin Cancer Prevalence Higher in Men Who Identify as Gay, Bisexual

February 26th 2020

Men who identify as gay or bisexual report having more skin cancers than those who identify as heterosexual. More frequent use of indoor tanning could be a cause, but researchers want to find out for sure.

Finding Purpose After Five Different Cancers

February 20th 2020

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Lainie Jones, who has found her purpose in helping others after being diagnosed with five separate primary cancers before the age of 35 because of a rare genetic condition that predisposes her to develop the disease.

Firstline: What's Making An Impact In The Cancer Landscape

February 19th 2020

From Neil Peart’s passing following a battle with brain cancer to a new online support group for men with testicular cancer, here’s the news making an impact in the cancer landscape.

Liquid Biopsy May Help Predict Relapse Risk in Patients with Advanced Melanoma

February 7th 2020

Patients with stage 3 melanoma who had one or more circulating tumor cells were found to relapse sooner, providing physicians with an important biomarker to treat the likelihood of relapse.

ASCO Names Refinement of Surgical Treatment as Advance of the Year in Cancer Care

February 6th 2020

The refinement of surgical treatment of cancer was named the American Society of Clinical Oncology’s advance of the year, according to its Annual Report on Progress Against Cancer.

I Never Met Frederic Mohs

February 4th 2020

Friday Frontline: Cancer Updates, Research and Education on January 24, 2020

January 24th 2020

From the FDA issuing a safety alert on cybersecurity vulnerabilities to health care facility technology to former Bachelorette star Ali Fedotowsky revealing she has basal cell carcinoma, here’s what is making headlines in the cancer space this week.

Immune-Related Side Effects After Keytruda Treatment Could Indicate Improved Responses

January 22nd 2020

Patients with high-risk stage 3 melanoma who experienced an immune-related side effect after treatment with adjuvant Keytruda had reduced risk for disease recurrence, compared with those on the placebo arm.

Online Educational Videos Prove Useful for Patients Looking To Understand Their Cancer

January 21st 2020

More people than ever are beginning their medical journeys online as digital videos on cancer education are proven to be a useful tool that institutions should provide.

In Cancer Treatment, Immunotherapy is a Viable Option Despite Toxicities

January 18th 2020

Because they have been found to be effective in the treatment of many types of cancer, including melanoma, immunotherapy drugs like anti-PD-1 agents and anti-CTLA4 therapies should not be discounted because of their toxicities.